Lipid peroxidation products can activate transcription factor NF-kB in patients with NAFLD [32], a key transcription factor that regulates the expression of several proinflammatory cytokines and hepatic inflammation. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.